Bumetanide administration attenuated traumatic brain injury through IL-1 overexpression
about
Novel treatment targets for cerebral edemaNeuroinflammation in the normal aging hippocampusAstaxanthin protects astrocytes against trauma-induced apoptosis through inhibition of NKCC1 expression via the NF-κB signaling pathwayThe role of estrogen and progesterone, administered alone and in combination, in modulating cytokine concentration following traumatic brain injury.Molecular mechanisms of microvascular failure in central nervous system injury--synergistic roles of NKCC1 and SUR1/TRPM4.Na-K-Cl Cotransporter-1 in the mechanism of ammonia-induced astrocyte swelling.Bumetanide promotes neural precursor cell regeneration and dendritic development in the hippocampal dentate gyrus in the chronic stage of cerebral ischemia.Excitatory action of GABA on immature neurons is not due to absence of ketone bodies metabolites or other energy substrates.The role of markers of inflammation in traumatic brain injury.Neuropathic pain: role of inflammation, immune response, and ion channel activity in central injury mechanisms.NKCC1 mediates traumatic brain injury-induced hippocampal neurogenesis through CREB phosphorylation and HIF-1α expression.Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches.Transient receptor potential vanilloid type 4 channels mediate Na-K-Cl-co-transporter-induced brain edema after traumatic brain injury.Microglia and CNS Interleukin-1: Beyond Immunological Concepts.
P2860
Q28254203-7C800203-E034-4D02-899E-FEA877C6784CQ28388537-D0FC6784-63CE-4259-8290-9AF608BFB131Q33660226-5DDBE6BF-FC8E-4F64-B4EE-0ED273A6B2DEQ34156670-B63DD261-227F-46B0-89FA-D06FA592321EQ34548221-8711820E-C1AB-4167-BF27-D7CC652D81A0Q36990177-E75B56EB-F50D-48B3-8DC2-AE73C6994634Q36996593-8D0A973F-7C81-4C92-9742-B6FB2F289743Q37892605-77A418CC-387E-41D3-8428-98E747E3CB1CQ38086443-35112E25-DE7C-4EF0-9EF5-1D3B91C414EEQ38247950-3B017D02-0697-4B93-A022-92512F7D94BBQ38304336-B2D95C83-9C57-4B99-81FC-F2A717E77939Q38318458-BADD46AD-E9C4-4F4F-B60F-EAD5DB3968BDQ48403239-07FFEB9C-26D5-401B-923C-DBCD89743B98Q49798820-FD74BC24-6E9D-4AFC-A65A-68388A2C7C34
P2860
Bumetanide administration attenuated traumatic brain injury through IL-1 overexpression
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Bumetanide administration attenuated traumatic brain injury through IL-1 overexpression
@ast
Bumetanide administration attenuated traumatic brain injury through IL-1 overexpression
@en
Bumetanide administration attenuated traumatic brain injury through IL-1 overexpression
@nl
type
label
Bumetanide administration attenuated traumatic brain injury through IL-1 overexpression
@ast
Bumetanide administration attenuated traumatic brain injury through IL-1 overexpression
@en
Bumetanide administration attenuated traumatic brain injury through IL-1 overexpression
@nl
prefLabel
Bumetanide administration attenuated traumatic brain injury through IL-1 overexpression
@ast
Bumetanide administration attenuated traumatic brain injury through IL-1 overexpression
@en
Bumetanide administration attenuated traumatic brain injury through IL-1 overexpression
@nl
P2093
P2860
P921
P3181
P356
P1476
Bumetanide administration attenuated traumatic brain injury through IL-1 overexpression
@en
P2093
Chang-Yen Wu
Chi-Ling Wang
Hao-Han Yen
Jeng-Hsiung F Peng
Kwok-Tung Lu
Yi-Ling Yang
P2860
P3181
P356
10.1179/016164107X204738
P407
P577
2007-06-01T00:00:00Z